Please assess the completion status of the following clinical trial:

Trial Title: Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells. PLASMACYTOKID

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Pediatric patients (0-18 years old):~   * Group 1 : Age\<8 years old~  * Group 2 : Age\>12 years old~2. Body weight \>10kgs~3. Pubescent (group 2) or non-pubescent (group 1)~4. Written consent of parents~Exclusion Criteria:~1. Active infectious disease~2. Known perturbations of immune and/or inflammatory systems~3. Oral or subcutaneous contraception in pubescent girls

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Group 1: non-pubescent children (Type: EXPERIMENTAL): 70 non-pubescent children (25 healthy boys, 25 healthy girls, 10 boys with Klinefelter syndrome and 10 girls with Turner syndrome) Two 7 ml tubes of blood will be taken to perform the functional assays as well as the quantification of Blood Plasmacytoid dendritic cells (pDCs) absolute number in this 70 non-pubescent children.
- Group 2: pubescent healthy children (Type: EXPERIMENTAL): 50 pubescent healthy children (25 boys and 25 girls) Two 7 ml tubes of blood will be taken to perform the functional assays as well as the quantification of Blood Plasmacytoid dendritic cells (pDCs) absolute number in this 50 pubescent healthy children.

Based on this trial design, predict the completion outcome and termination type (if applicable).